期刊
NUCLEIC ACIDS RESEARCH
卷 43, 期 10, 页码 5130-5144出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkv210
关键词
-
资金
- European Research Council [311257]
- I-CORE Program of the Planning and Budgeting Committee
- Israel Science Foundation [41/11, 1796/12]
- European Research Council (ERC) [311257] Funding Source: European Research Council (ERC)
Cancer is a complex disease that involves aberrant gene expression regulation. Discriminating the modified expression patterns driving tumor biology from the many that have no or little contribution is important for understanding cancer molecular basis. Recurrent deregulation patterns observed in multiple cancer types are enriched for such driver events. Here, we studied splicing alterations in hundreds of matched tumor and normal RNA-seq samples of eight solid cancer types. We found hundreds of cassette exons for which splicing was altered in multiple cancer types and identified a set of highly frequent altered splicing events. Specific splicing regulators, including RBFOX2, MBNL1/2 and QKI, appear to account for many splicing alteration events in multiple cancer types. Together, our results provide a first global analysis of regulated splicing alterations in cancer and identify common events with a potential causative role in solid tumor development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据